Mammalian target of rapamycin (mTOR) Inhibitors (Q35642619)

9 August 2017

1 reference

title

Mammalian target of rapamycin (mTOR) Inhibitors (English)

1 reference

9 August 2017

1 reference

1

Janice P Dutcher

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

published in

Current Oncology Reports

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

111-115

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Targeting mTOR signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Phospholipase D confers rapamycin resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0022-5

Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor.

21 January 2018

1 reference

12 December 2020

Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

1 reference

12 December 2020

Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation

1 reference

12 December 2020

Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.

1 reference

12 December 2020

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization

1 reference

12 December 2020

Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition

1 reference

12 December 2020

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

1 reference

12 December 2020

Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells

1 reference

12 December 2020

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1007/S11912-004-0022-5

1 reference

9 August 2017

1 reference